• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻女性产后乳腺癌的总生存率最低。

Overall survival is the lowest among young women with postpartum breast cancer.

机构信息

Young Women's Breast Cancer Program, University of Colorado Cancer Center, Aurora, CO, USA; Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.

Department of Biostatistics and Bioinformatics, University of Colorado Denver, Aurora, CO, USA.

出版信息

Eur J Cancer. 2022 Jun;168:119-127. doi: 10.1016/j.ejca.2022.03.014. Epub 2022 May 4.

DOI:10.1016/j.ejca.2022.03.014
PMID:35525161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9233962/
Abstract

BACKGROUND

Women diagnosed with breast cancer prior to age 45 years (<45y) and within the first 5 years postpartum (postpartum breast cancer, PPBC) have the greatest risk for distal metastatic recurrence.

METHODS

Pooling data from the Colorado Young Women Breast Cancer cohort and the Breast Cancer Health Disparities Study (N = 2519 cases), we examined the association of parity, age, and clinical factors with overall survival (OS) of breast cancer over 15 years of follow-up.

RESULTS

Women with PPBC diagnosed at <45y had the lowest OS (p < 0.0001), while OS of nulliparous cases diagnosed at <45y did not differ from OS of cases diagnosed at 45-65y regardless of parity status. After adjustment for study site, race/ethnicity, clinical stage, year of diagnosis and stratification for oestrogen receptor status, PPBC remained an independent factor associated with poor OS. Among cases diagnosed at <45y, nulliparous cases had 1.6 times better OS (hazard ratio (HR) = 0.61, 95%CI 0.42-0.87) compared to those with PPBC, with a more pronounced survival difference among stage I breast cancers (HR = 0.30, 95%CI 0.11-0.79). Among very young women diagnosed at age ≤35y, nulliparous cases had 2.3 times better OS (HR = 0.44, 95%CI 0.23-0.84) compared to PPBC.

CONCLUSION

Our results suggest that postpartum status is the main driver of poor prognosis in young women with breast cancer, with the strongest association in patients diagnosed at age ≤35y and in those with stage I disease.

摘要

背景

45 岁以下(<45y)和产后 5 年内(产后乳腺癌,PPBC)被诊断患有乳腺癌的女性发生远端转移性复发的风险最高。

方法

我们汇集了科罗拉多州年轻女性乳腺癌队列和乳腺癌健康差异研究(N=2519 例病例)的数据,研究了生育次数、年龄和临床因素与 15 年以上随访的乳腺癌总体生存率(OS)之间的关系。

结果

<45y 被诊断为 PPBC 的女性 OS 最低(p<0.0001),而 <45y 被诊断为未生育的病例的 OS 与 45-65y 被诊断为病例的 OS 没有差异,无论其生育状态如何。在校正研究地点、种族/族裔、临床分期、诊断年份和雌激素受体状态分层后,PPBC 仍然是与不良 OS 相关的独立因素。在<45y 被诊断为病例的女性中,未生育的病例 OS 更好,风险比(HR)为 0.61(95%CI 0.42-0.87),与 I 期乳腺癌的生存差异更为明显(HR 为 0.30,95%CI 0.11-0.79)。在≤35y 被诊断为非常年轻的女性中,未生育的病例 OS 更好,风险比(HR)为 0.44(95%CI 0.23-0.84)。

结论

我们的研究结果表明,产后状态是年轻乳腺癌患者预后不良的主要驱动因素,在≤35y 被诊断为病例和 I 期疾病的患者中关联最强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/66c833909370/nihms-1791923-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/e2dcbf385205/nihms-1791923-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/17b6fd578762/nihms-1791923-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/3c4f6ebd841a/nihms-1791923-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/66c833909370/nihms-1791923-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/e2dcbf385205/nihms-1791923-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/17b6fd578762/nihms-1791923-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/3c4f6ebd841a/nihms-1791923-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad5/9233962/66c833909370/nihms-1791923-f0004.jpg

相似文献

1
Overall survival is the lowest among young women with postpartum breast cancer.年轻女性产后乳腺癌的总生存率最低。
Eur J Cancer. 2022 Jun;168:119-127. doi: 10.1016/j.ejca.2022.03.014. Epub 2022 May 4.
2
Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.产后乳腺癌诊断与转移的相关性及其潜在风险的临床特征。
JAMA Netw Open. 2019 Jan 4;2(1):e186997. doi: 10.1001/jamanetworkopen.2018.6997.
3
Clinical characteristics and prognosis of postpartum breast cancer.产后乳腺癌的临床特征和预后。
Breast Cancer Res Treat. 2023 Nov;202(2):275-286. doi: 10.1007/s10549-023-07069-w. Epub 2023 Aug 5.
4
Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.犹他州近期分娩后时间与青年期乳腺癌结局的关系。
JAMA Netw Open. 2022 Oct 3;5(10):e2236763. doi: 10.1001/jamanetworkopen.2022.36763.
5
Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.产后诊断显示出较高的转移风险,值得对妊娠相关性乳腺癌进行更广泛的定义。
Breast Cancer Res Treat. 2013 Apr;138(2):549-59. doi: 10.1007/s10549-013-2437-x. Epub 2013 Feb 22.
6
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.产后乳腺癌具有独特的分子特征,预示着不良预后。
Nat Commun. 2021 Nov 3;12(1):6341. doi: 10.1038/s41467-021-26505-3.
7
Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival.产后乳腺癌的进展是由信号素 7a 介导的侵袭和存活所驱动的。
Oncogene. 2020 Mar;39(13):2772-2785. doi: 10.1038/s41388-020-1192-9. Epub 2020 Feb 4.
8
Worse histopathology and prognosis in women with breast cancer diagnosed during the second trimester of pregnancy.妊娠中期诊断乳腺癌的女性患者组织病理学表现更差,预后更差。
ESMO Open. 2024 Apr;9(4):102972. doi: 10.1016/j.esmoop.2024.102972. Epub 2024 Mar 22.
9
Prognosis of pregnancy-associated breast cancer: a meta-analysis.妊娠相关性乳腺癌的预后:一项荟萃分析。
BMC Cancer. 2020 Aug 10;20(1):746. doi: 10.1186/s12885-020-07248-8.
10
The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis.孕期前、孕期及产后被诊断为乳腺癌的女性的预后:一项荟萃分析。
Breast Cancer Res Treat. 2016 Nov;160(2):347-360. doi: 10.1007/s10549-016-3989-3. Epub 2016 Sep 28.

引用本文的文献

1
Pregnancy and breast cancer in young women: current updates and future directions.年轻女性的妊娠与乳腺癌:当前进展与未来方向
Ther Adv Med Oncol. 2025 Sep 6;17:17588359251369973. doi: 10.1177/17588359251369973. eCollection 2025.
2
Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer.信号素7A和程序性死亡受体配体1在乳腺退化和乳腺癌过程中协同驱动免疫抑制。
Cell Rep. 2025 May 27;44(5):115676. doi: 10.1016/j.celrep.2025.115676. Epub 2025 May 6.
3
Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies.

本文引用的文献

1
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network.妊娠相关三阴性乳腺癌的预后:来自法国 CALG(妊娠相关癌症)网络的倾向评分匹配分析。
Breast. 2022 Feb;61:168-174. doi: 10.1016/j.breast.2022.01.004. Epub 2022 Jan 10.
2
Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.哺乳期后诊断出的乳腺癌预示着不良预后。
Eur J Cancer. 2021 Sep;155:13-24. doi: 10.1016/j.ejca.2021.06.009. Epub 2021 Jul 27.
3
The definition of pregnancy-associated breast cancer is outdated and should no longer be used.
了解乳腺癌易感性:从风险因素到预防策略。
Int J Mol Sci. 2025 Mar 25;26(7):2993. doi: 10.3390/ijms26072993.
4
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes.解析罕见乳腺癌亚型的复杂性并把握机遇。
NPJ Breast Cancer. 2025 Jan 24;11(1):6. doi: 10.1038/s41523-025-00719-w.
5
Bibliometric and visual analysis of human microbiome-breast cancer interactions: current insights and future directions.人类微生物组与乳腺癌相互作用的文献计量学和可视化分析:当前见解与未来方向
Front Microbiol. 2024 Dec 9;15:1490007. doi: 10.3389/fmicb.2024.1490007. eCollection 2024.
6
Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy.孕期接受化疗的乳腺癌患者与接受全身治疗的非妊娠乳腺癌患者的治疗结果比较。
Cancer. 2025 Jan 1;131(1):e35619. doi: 10.1002/cncr.35619. Epub 2024 Oct 29.
7
Altered liver metabolism post-wean abolishes efficacy of vitamin D for breast cancer prevention in a mouse model.断奶后肝脏代谢的改变消除了维生素D在小鼠模型中预防乳腺癌的功效。
bioRxiv. 2024 Jun 2:2024.05.28.596304. doi: 10.1101/2024.05.28.596304.
8
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.遗传性 BRCA 种系致病性变异女性的产后乳腺癌与生存
JAMA Netw Open. 2024 Apr 1;7(4):e247421. doi: 10.1001/jamanetworkopen.2024.7421.
9
Early-Stage Breast Cancer Detection in Breast Milk.早期乳腺癌在母乳中的检测。
Cancer Discov. 2023 Oct 5;13(10):2180-2191. doi: 10.1158/2159-8290.CD-22-1340.
10
Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer.产后乳腺癌患者新辅助化疗后的临床特征及病理完全缓解(pCR)率
J Cancer Res Clin Oncol. 2023 Nov;149(15):14185-14204. doi: 10.1007/s00432-023-05194-z. Epub 2023 Aug 9.
妊娠相关乳腺癌的定义已过时,不应再使用。
Lancet Oncol. 2021 Jun;22(6):753-754. doi: 10.1016/S1470-2045(21)00183-2.
4
Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation.产后乳腺癌:其预后不良的机制、治疗意义和生育力保护。
Int J Gynecol Cancer. 2021 Mar;31(3):412-422. doi: 10.1136/ijgc-2020-002072.
5
Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?产后恢复与癌症:有机会针对乳腺癌进行预防和治疗吗?
Cancer Res. 2020 May 1;80(9):1790-1798. doi: 10.1158/0008-5472.CAN-19-3448. Epub 2020 Feb 19.
6
Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention.妊娠与乳腺癌:理解风险和预防的途径。
Trends Mol Med. 2019 Oct;25(10):866-881. doi: 10.1016/j.molmed.2019.06.003. Epub 2019 Aug 2.
7
Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.产后乳腺癌诊断与转移的相关性及其潜在风险的临床特征。
JAMA Netw Open. 2019 Jan 4;2(1):e186997. doi: 10.1001/jamanetworkopen.2018.6997.
8
The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis.啮齿动物肝脏会经历断奶诱导的退化,并支持乳腺癌转移。
Cancer Discov. 2017 Feb;7(2):177-187. doi: 10.1158/2159-8290.CD-16-0822. Epub 2016 Dec 14.
9
The Interaction between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic Women: The Breast Cancer Health Disparities Study.西班牙裔女性遗传血统与乳腺癌风险因素之间的相互作用:乳腺癌健康差异研究。
Cancer Epidemiol Biomarkers Prev. 2017 May;26(5):692-701. doi: 10.1158/1055-9965.EPI-16-0721. Epub 2016 Dec 8.
10
Long-term outcome in young women with breast cancer: a population-based study.年轻女性乳腺癌患者的长期预后:一项基于人群的研究。
Breast Cancer Res Treat. 2016 Nov;160(1):131-143. doi: 10.1007/s10549-016-3983-9. Epub 2016 Sep 13.